Latest DRC News
- Details
A researcher at the University of Alabama at Birmingham Department of Pathology has received an R21 award from the National Institute on Alcohol Abuse and Alcoholism. This grant will be used to better understand whether disruptions in circadian rhythm can negatively influence liver health and whether these disruptions are risk factors for alcohol-related liver disease.
- Details
The University of Alabama at Birmingham Department of Family and Community Medicine’s Vice Chair for Research Tapan Mehta, Ph.D., is partnering with investigators at the University of Mississippi Medical Center to lead a $3.6 million study to develop a sustainable and effective Type 2 diabetes management intervention in adults who have Type 2 diabetes and sub-optimal social determinants of health.
- Details
George Howard, DrPH, Distinguished Professor in the Department of Biostatistics, retired from the UAB School of Public Health on November 1, 2022. Dr. Howard’s career in Public Health and Medicine spans more than 40 years at UAB and previously at Wake Forest School of Medicine (previously Bowman Gray School of Medicine). Dr. Howard has also held visiting professor or adjunct positions at the Polish Mother's Memorial Hospital Research Institute in Lodz, Poland, and East Carolina University.
- Details
New research presented by University of Alabama at Birmingham researchers shows that a 2.4mg dose of the obesity drug semaglutide can reduce the risk of Type 2 diabetes, or T2D, by 60 percent.
- Details
In groundbreaking diabetes research over the past two decades, Anath Shalev, M.D., has shown that the protein TXNIP regulates survival and function of beta cells, the pancreatic cells that produce the hormone insulin to lower levels of glucose in the blood. Downregulation or inhibition of TXNIP in beta cells protects against diabetes in mouse models, and a repurposed clinical drug that inhibits TXNIP shows promising results in people with recent-onset Type 1 diabetes.
- Details
Alabama, a state with many counties in the United States Diabetes Belt, saw an increase in new-onset Type 2 diabetes among youth during the COVID-19 pandemic. Results published in the Journal of Clinical Endocrinology & Metabolism showed the significant increase and indicated that Medicaid enrollees and males were disproportionately affected by the disease.
- Details
Carbohydrates are directly linked to the development of Type 2 diabetes, but a higher-carb diet is underused in research models.
- Details
A study from the University of Alabama at Birmingham is looking into a drug-free approach to treat type 2 diabetes. The research focuses on using diet changes to target the fat around organs like the pancreas and liver.
- Details
W. Timothy Garvey, M.D., was named University Professor in the School of Health Professions Department of Nutrition Sciences. Garvey joined UAB in 2003 as chair of the Department of Nutrition Sciences, where he served until 2018.
- Details
A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet. The therapy acts through sustained release of nitric oxide, a gaseous signaling chemical whose most important function in the body is relaxing the inner muscles of blood vessels.